We tested the hypothesis that the time course of the evolution of antifungal drug resistance depends on the ploidy of the fungus. The experiments were designed to measure the initial response to the selection imposed by the antifungal drug fluconazole up to and including the fixation of the first resistance mutation in populations of Saccharomyces cerevisiae. Under conditions of low drug concentration, mutations in the genes PDR1 and PDR3, which regulate the ABC transporters implicated in resistance to fluconazole, are favored. In this environment, diploid populations of defined size consistently became fixed for a resistance mutation sooner than haploid populations. Experiments manipulating population sizes showed that this advantage of diploids was due to increased mutation availability relative to that of haploids; in effect, diploids have twice the number of mutational targets as haploids and hence have a reduced waiting time for mutations to occur. Under conditions of high drug concentration, recessive mutations in ERG3, which result in resistance through altered sterol synthesis, are favored. In this environment, haploids consistently achieved resistance much sooner than diploids. When 29 haploid and 29 diploid populations were evolved for 100 generations in low drug concentration, the mutations fixed in diploid populations were all dominant, while the mutations fixed in haploid populations were either recessive (16 populations) or dominant (13 populations). Further, the spectrum of the 53 nonsynonymous mutations identified at the sequence level was different between haploids and diploids. These results fit existing theory on the relative abilities of haploids and diploids to adapt and suggest that the ploidy of the fungal pathogen has a strong impact on the evolution of fluconazole resistance.
T HE predicted advantages and disadvantages of hapotide site, and their level of dominance can be measured loidy and diploidy, like those of recombination (Kondirectly. drashov 1993), hinge on the ability of populations (a) Two factors are preeminent in determining the effect to cope with deleterious mutation (Kondrashov and of ploidy on the rate of adaptation (Orr and Otto 1994) : Crow 1991) and (b) to adapt to new environments (Orr the waiting time for mutations to appear and the fixation and Otto 1994). Our goal in this study was to make a time required for mutations to spread to high frequency direct comparison of ploidy states by measuring the in a population in response to directional selection. Under relative abilities of isogenic haploids and diploids of the conditions of finite population size where the waiting yeast Saccharomyces cerevisiae to adapt to the presence of time for beneficial mutations is the rate-limiting step in the antifungal drug fluconazole (FLC). We followed the adaptation, diploids should, at first glance, have the faster initial, rather than the long-term, responses of haploid rate of adaptation. This is because diploids have twice the and diploid populations to pinpoint the relative advannumber of targets for mutations, resulting in a higher tages and disadvantages of each of the two ploidy states frequency of mutations conferring increased fitness. This in adaptation and to minimize the potentially confoundadvantage for diploids, however, accrues only when the ing effects of the genetic divergence that may accumulate mutations are sufficiently dominant in their effect on with long-term evolution. Antifungal drug resistance is an phenotype. Where the mutations are recessive, haploids excellent model for adaptation because the fitness increshould have the advantage because the fixation time, ments with each mutation are large (Anderson et al. rather than the waiting time, is the rate-limiting step. 2003) , the underlying molecular mechanisms are well Under these conditions, haploids that are hemizygous documented (Sanglard et al. 1998; White et al. 1998;  for beneficial mutations respond more efficiently to se- Lupetti et al. 2002; Sanglard and Odds 2002) , the lection than diploids that are heterozygous for mutamutations can be readily mapped to the gene and nucletions.
In a previous study, we showed that drug concentration determines which kinds of FLC-resistance mutations are mating types with ura3, but none of the other auxotrophies, two regulators of the ABC transporters (the other is were crossed to form two strains that were PDR1/PDR1 PDR3/ PDR3, see below), are common in replicate populations.
PDR3 and two that were PDR1/PDR1⌬ PDR3/PDR3⌬. Further, These mutations raise the minimum inhibitory concenthe two diploid strains that were heterozygous for deletions tration (MIC) for FLC only to intermediate levels (MIC at PDR1 and PDR3 were allowed to sporulate and nonparental ditype tetrads segregating 2:2 for resistance to G418 were identi-64 g/ml) and are dominant, at least in drug concentrafied; double mutants (PDR1⌬ PDR3⌬) of compatible mating tions below the MIC. When the drug concentration is types were crossed to form two diploid strains that were PDR1⌬/ raised in several increments, populations with mutations
in PDR1 become fixed for mutations in a second gene, MIC tests: MIC assays were in 96-well microtiter plates with as yet unidentified, to reach the highest measurable level 0.2 ml of 0.5ϫ YPD and 0, 16, 32, 64, 128 , and 256 g/ml FLC as described by Anderson et al. (2003) . Cell densities of resistance (MIC 256 g/ml). This ordered succession were measured in 24-hr-old, 10-ml cultures. From these culof mutations was observed in parallel in three different tures, ‫01ف‬ 3 cells, or fewer, were inoculated to each test well.
populations. Interestingly, the PDR1 mutations, the first In contrast, when populations of wild-type, drug-sensiability to undergo seven to nine doublings at 32 g/ml FLC tive cells are abruptly subjected to a high drug concenand higher (Anderson et al. 2003) , the basal population size tration, mutations raising the MIC to the highest level of both haploids and diploids was expected to reach 10 Anderson et al. (2003) were used; these strains were all URA3⌬::KANMX4 and were derivatives of S288C. All replicate culture, the same cultures used to determine the MIC of FLC, were grown to midlog phase in the absence of FLC cultures were maintained in liquid, half-strength yeast peptone dextrose (0.5ϫ YPD) medium on an orbital shaker at 30Њ.
and RNA was extracted exactly as described by Anderson et al. (2003) . Northern blots, probes, hybridization, and phosphorArchives were maintained in 15% glycerol at Ϫ80Њ. Subcultures from all experiments described below are available on imagery were also as described by Anderson et al. (2003) . As before, YEF 3 was the internal standard for gene expression request.
In addition, diploid strains carrying replacements at PDR1 and the expression values of each evolved strain were relative to its respective progenitor. Detailed genetic characterization and PDR3 by the KanMX4 cassette were constructed for control experiments. The initial haploid deletion strains from the of the mutations was reserved for the next round of experiments described below. yeast knockout collection were MATa his3⌬1 leu2⌬0 met15⌬0 ura3⌬0. These were crossed with an otherwise isogenic MAT␣ Replicate populations in 16 g/ml FLC: To compare the spectrum of mutations fixed by haploids and diploids, 29 repliura3 strain. From the progeny, haploid strains of compatible cate populations of the MATa haploid and 29 replicated of between either of the genes and their respective centromeres. With occasional crossovers between these genes and their rethe MATa/␣ diploid were established in 1 ml of 0.5ϫ YPD. These cultures were batch transferred daily at a dilution rate spective centromeres, however, the probability of a spurious match becomes even lower. of 1:10 for the first 50 generations. This dilution rate has been shown to be optimal for the fixation of mutations conferring Sequencing: The progenitor haploid plus one resistant haploid strain from each of the 58 populations were selected for adaptive advantage in a given environment (Wahl and Krakauer 2000) . Cultures were then batch transferred at a dilusequencing of PDR1 (Kolaczkowska et al. 2002) and PDR3 (Nourani et al. 1997 ) regions known to accumulate FLCtion rate of 1:100 for the next 50 generations. For the first few transfers after their establishment, the maximum density resistance mutations. For each of these strains, the DNA was fully sequenced over bases 600-1075 and 1800-3207 of PDR1 of the batch cultures with FLC was reduced 30-50%, relative to the density in control populations without the drug. In all and 730-1070 and 1830-2931 of PDR3. In each gene these regions included the MI II domains and the transcription populations with FLC, maximum density then recovered to 1 near the levels in the controls without FLC. At the end of 100 activation domains near the C terminus that encompass all previously identified mutations in these genes. Amplification generations, a single-colony isolate was recovered from each population and archived for further analysis.
primers and sequencing primers spaced at 400-500 bases on each DNA strain were selected with the primer design option The 29 diploid cultures evolved with FLC were allowed to sporulate and three to five tetrads were dissected for each.
provided by the Saccharomyces genome database (http:/ / www.yeastgenome.org/). Sequencing was exactly as described All tetrads segregated for lower MIC (16 g/ml)/higher MIC (64 or 32 g/ml), consistent with a single mutation for resisearlier (Anderson et al. 2003) . tance heterozygous with the wild type. A MATa progeny strain of higher MIC was selected for further tests. From the 29 haploid populations evolved with FLC, single-colony isolates RESULTS (also MATa) were also subjected to the same tests.
To measure the dominance of the mutations, haploid MATa
Evolution of haploids and diploids at various FLC
strains derived from the 29 diploid and 29 haploid populations concentrations: Haploids and diploids showed three difafter 100 generations in 16 mg/ml FLC were mated with a ferent patterns of evolution of resistance ( Figure 1 ). (a) when the mutation was hemizygous in a haploid back-
Among the three single colonies tested for MIC and gene ground and (b) when the same mutation was heterozygous expression from each replicate flask, there was no eviwith the progenitor allele in a diploid background; all of these dence of polymorphism for the resistance phenotype.
strains had MICs Ͼ16 g/ml. In contrast, strains carrying a Second, at 32 g/ml FLC, the diploids reached a recessive mutation grew to maximum density at 16 mg/ml FLC only when the mutation was hemizygous in a haploid significantly higher culture density than the haploids at background; these strains all had MICs Ͼ16 g/ml. When the day 2 (two-tailed t-test assuming unequal variance, P ϭ same recessive mutation was heterozygous with the progenitor 0.000), while the haploids showed marked increases in allele in a diploid background, these strains grew poorly ‫9-7ف diploid replicates showed evidence of an increase in hypothesis that the apparent advantage of the diploids on day 3 of the experiment at 32 g/ml FLC ( Figure  MIC over the basal level and in most of these there was a corresponding increase in expression of ERG11. By 1b) was due to a reduced waiting time relative to that of the haploids. If so, then reducing the diploid inocuday 9, however, the diploid cultures had all risen to high density, and all isolates had high MICs and overexlum by half relative to that of the haploid populations should erase this advantage. Further, doubling the happressed ERG11 (data not shown).
Haploids, diploids, and the waiting time for resistance loid inoculum relative to that of the diploids should bring the haploid density up to that of the diploids on mutations: The next experiments were done to test the were homozygous wild type for each gene, two strains were heterozygous for each wild-type gene and its respective deletion, and two strains were homozygous for day 2. These expectations were confirmed (Figure 2) : the deletion. Three replicate 50-ml cultures of each when the diploid populations were started with half the strain (18 in total) were inoculated as above with 5 ϫ inoculum of the haploids (2.5 ϫ 10 4 rather than 5 ϫ 10 4 cells. The prediction was that cultures of the wild-10 4 cells), the increase in the mean density of the diptype homozygotes (i.e., diploid for PDR1 and PDR3) loids was delayed one full day compared to that in Figure  should rise to high density first, followed by the heterozy1b and almost exactly matched that of the haploids on gotes (i.e., haploid for PDR1 and PDR3), followed even day 4 (P ϭ 0.41, Figure 2b ). In contrast, the trajectory later by the homozygous deletion strains (null for PDR1 of the increase among the haploids in Figure 2a closely and PDR3). This prediction was confirmed (Figure 3 ). matched that of the previous experiment in which the Although peripheral to our main prediction, it was curiinoculum size was the same (Figure 1b) .
ous that the wild-type, homozygous and the heterozyIn the converse experiment, in which the haploids gous constructs did not reach the same final density by were started with double their previous inoculum size day 5; this unexpected effect could have been due to (10 5 rather than 5 ϫ 10 4 cells), the haploids showed a many factors, such as a relationship between altered prominent increase in density on day 3 and their mean ratios of the regulatory proteins Pdr1p and Pdr3p and density nearly matched that of the diploids. Again, the their targets and ability of cells to tolerate high populadifference was not significant (P ϭ 0.11). The diploids tion density, but not to ploidy per se. in Figure 2b matched their trajectory of increase in Spectrum of mutations at 16 g/ml FLC: Next, we density observed in the comparable experiment in Figcompared the distribution of mutations in haploids and ure 1b.
diploids evolving over 100 generations in a low concenIn the above tests of the waiting time, a potential tration of FLC (Table 1) in which mutations in PDR1 problem of interpretation is that two different cell types or PDR3 are most likely to be fixed in both haploids are being compared. In addition to the different numand diploids. The dominance level of the 29 mutations ber of genomes present, haploid and diploid cells differ occurring in haploid populations was variable with 16 markedly in their size, shape, and pattern of budding.
recessive and 13 dominant. In contrast, all of the 29 The rationale for the next experiments was to compare mutations from the diploid populations were dominant effectively diploid, haploid, and null genotypes for the in the test environment with 16 g/ml FLC; the differprimary candidate genes for adaptive mutation, PDR1 ence in the distribution of dominant and recessive mutaand PDR3, in a generally diploid background. In this tions from haploid and diploid populations was highly diploid background, the frequent, loss-of-function musignificant (chi-square test, 1 d.f., P Ͻ 0.001). Of the tations at ERG3 would not confer an immediate advantotal of 58 mutations fixed in populations, 52 were identage and the cell type was held constant. We therefore tified at the nucleotide sequence level in the sequenced constructed otherwise isogenic diploid strains that varregions of either PDR1 or PDR3 (Table 1 and Figure 4 ) and in all of these cases the determined map location ied in the numbers of PDR1 and PDR3 genes. Two strains Figure 4.-Distribution of nonsynonymous mutations in PDR1 and PDR2 in haploid and diploid populations evolved for 100 generations in 16 mg/ml FLC.
DISCUSSION
agreed with the sequence information. All of these mutations were nonsynonymous and no other mutations
The haploid and diploid yeast populations in this were observed. The progenitor also showed no deparstudy showed prominent and complementary advanture from the standard sequence. Among the haploids tages and disadvantages in adapting to the presence of two unidentified mutations did not map to either PDR1 the antifungal drug fluconazole. The clear advantage of or PDR3. Of these one had a high MIC and was comdiploids over haploids at low fluconazole concentration pletely recessive, the hallmarks of loss of function at follows from two conditions. First, these experimental ERG3. This mutation was later identified at the DNA populations were of low initial size (5 ϫ 10 4 cells) and sequence level (Table 1) . the waiting time must have been the rate-limiting step Several mutations occurred in parallel in different in adaptation. Given a per-gene mutation rate of 10 Ϫ6 populations including Phe739Ile (two haploid populafrom an approximate per-nucleotide mutation rate of tions), Phe749Ser (1 diploid and 1 haploid population), 10 Ϫ9 and an average gene size of 10 3 nucleotides, these and Lys302Asn (2 diploid populations) in PDR1 and populations were likely devoid of resistance mutations Gly253Val (4 haploid populations), Cys707Phe (3 hapfor the first several generations. Indeed, populations of loid populations), and, most remarkably, Val945Phe (2 even lower initial size (10 or 20 cells) failed to evolve haploid and 16 diploid populations) in PDR3. In PDR1, resistance at 32 g/ml FLC or higher concentrations. one amino acid position was substituted for three differSecond, the mutations in PDR1 and PDR3 strongly faent amino acids: Arg821His (1 haploid population), vored at low drug concentrations were sufficiently domiArg821Leu (1 diploid population), and Arg821Ser (1 nant in heterozygous diploids to confer a large selective diploid population). Several of these mutations have advantage over the drug sensitive, ancestral type. occurred independently in previous studies. In all but
The difference in the time to fixation of the first one case, the same substitution occurring indepenmutation between haploids and diploids at 32 g/ml dently in different populations conferred the same level FLC can be attributed to ploidy, and not to other factors, of dominance; the only anomaly was Phe739Ser in for the following reasons. First, the haploid and diploid PDR1, which for reasons unknown appeared to be domicells used in these experiments were all initially isogenic nant in one population, but recessive in another. In and so the background genotype was not a factor. Secthree of the four regions sequenced the diversity of ond, there was no detectable effect of mating type on mutations was less in the diploid than in the haploid adaptation. Third, when the initial population size of populations, and especially so in the transcription activation domain of PDR3.
the diploid populations was halved, their advantage was erased. Conversely, when the initial populations of the were different and the mutations responsible for increased fitness were of smaller effect than those observed here. haploid populations were doubled, their disadvantage was nearly eliminated. And finally, in additional control
In the short-term evolution experiments with a maximum of 22 generations, the populations showed clear experiments in which the number of functional PDR1 and PDR3 genes was varied in diploid strains, as exdifferences in their trajectories of adaptation based on their ploidy, but these populations were not necessarily pected, the wild types evolved resistance first, followed by the strains heterozygous for the gene deletions, folall fixed for single mutations. To examine the spectrum of mutations favored in haploid and diploid populations lowed by the diploid strains homozygous for the gene deletions. Consequently, cell-type differences between at a low concentration of FLC, we next evolved populations in batch culture with daily dilution and transfer haploids and diploids could not have been a factor. The results all coincided closely with those expected when to encourage the fixation of single mutations that could then be characterized genetically and at the nucleotide the waiting time is the rate-limiting step of adaptation and greater numbers of copies of the target genes for sequence level. In these experiments, there was a clear difference between haploids and diploids even in the mubeneficial mutations confer an advantage. The simple reason for the decreased waiting time is that diploid tations in PDR1 and PDR3, where the availability of these mutations is greatest for both haploids and diploids. Conpopulations have twice as many genome equivalents and hence twice as many mutational targets as haploid popusistent with expectation, the haploids showed a greater diversity of mutations than diploids, with a greater range lations have with the same numbers of individuals.
Although diploids were at an advantage at the lower of dominance (16 recessive, 13 dominant) than that in diploids (all 29 dominant). Although the potential muend of the spectrum of drug concentration, haploids were at an advantage over diploids at the high end of the drugtational spectrum was probably not saturated in these experiments, a number of independent changes in the concentration range. This is explained by the recessive nature of the ERG3 mutations most frequently favored at same nucleotide site were observed. Most striking was the frequency of fixation of the Val945Phe mutation these concentrations and the resulting greater efficiency of selection of these mutations in haploids than in hetin diploids in 17 of 27 diploid populations for which mutations were identified at the sequence level. Alerozygous diploids. At high drug concentrations, individual PDR1 and PDR3 mutations are not strong enough though two haploids also fixed this same mutation, they had a much greater diversity of mutation at PDR3. in their effect on resistance to be favored in either haploids or diploids and indeed show a pronounced What are the general implications of our results for the evolution of antifungal drug resistance in fungal fitness deficit compared with the ancestral drug-sensitive type at the highest drug concentrations. That diploids populations infecting patients? In opportunistic fungal pathogens ploidy is well known to vary among species. ultimately did become resistant by day 9, and showed gene expression patterns consistent with loss of function For example, Candida albicans is diploid (Berman and Sudbery 2002) , while C. glabrata is haploid (Fidel et al. at ERG3 , is best explained by loss of heterozygosity and the delayed exposure of ERG3 to selection as homozy-1999; Dodgson et al. 2003) . Because fungal pathogens of humans live in highly structured environments, the gotes. MATa/␣ diploids did not segregate for resistance; all progeny had MICs of 256 g/ml FLC (data not effective size of their populations is likely much lower than those of well-mixed, planktonic, yeast cultures. shown). The requirement for mitotic recombination, in the form of either mitotic crossing over or local gene Waiting time could well be a rate-limiting step in the evolution of resistance in the host environment and this conversion, imposes an extra step on diploids relative to haploids and this further retards the rate of adaptation. may favor diploid pathogens if sufficiently dominant mutations for resistance are available in their populaThe advantages and disadvantages associated with haploidy and diploidy seen here were dependent on tions. It would be interesting to specifically compare the kinds of resistance arising in the haploid C. glabrata conditions, primarily the drug concentration, which determined the kinds of resistance mutations that were and the diploid C. albicans across uniform clinical settings and drug-treatment regimens; from the present favored in the experimental populations. The absence of a general rule for the advantages and disadvantages study, our prediction is a more frequent occurrence of loss-of-function ERG3 mutations in C. glabrata than in of a particular ploidy state is consistent with previous studies, which have demonstrated both diploid and hap-C. albicans. A second implication of our results is that antifungal loid advantages in the rate of adaptation. For example, diploid populations had a clear advantage over haploid drugs could potentially be deployed to manage resistance in fungal pathogens if the fitness effects of their populations in adapting to glucose limitation in chemostats (Paquin and Adams 1983) , while haploid popula-2 resistance mutations in the host mirror those of S. cerevisiae seen here. For example, as noted above, haploid tions had at least a transient advantage over diploid populations in adapting to a minimal medium in serially populations may be expected to evolve high resistance in one step in high drug concentrations through loss transferred batch cultures (Zeyl et al. 2003) . In these previous studies, however, the conditions for selection of function at ERG3 much more readily than diploids.
